New opportunities for nanoparticles in cancer immunotherapy

BACKGROUND: Recently, cancer immunotherapy has become standard for cancer treatment. Immunotherapy not only treats primary tumors, but also prevents metastasis and recurrence, representing a major advantage over conventional cancer treatments. However, existing cancer immunotherapies have limited cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Wooram, Heo, Young-Jae, Han, Dong Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158870/
https://www.ncbi.nlm.nih.gov/pubmed/30275967
http://dx.doi.org/10.1186/s40824-018-0133-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158870/
https://www.ncbi.nlm.nih.gov/pubmed/30275967
http://dx.doi.org/10.1186/s40824-018-0133-y

Ejemplares similares